Pricing

Concert Pharmaceuticals Inc (CNCE)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Roger D. Tung
Employees:
60
65 HAYDEN AVENUE, SUITE 3000N, LEXINGTON, MA, 02421
781-860-0045
Concert Pharmaceuticals, Inc. develops novel small molecule drugs for the treatment of autoimmune diseases. Lead product candidate is CTP-543, which is in Phase III clinical trial for treatment of alopecia areata, a serious autoimmune dermatological condition. Company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available